Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 1812Session 89R

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

Introduced

Underlined text would be added to current law. Struck-through text would be removed.

  89R12618 DNC-D
 
  By: Campbell, Menéndez S.B. No. 1812
 
 
  A BILL TO BE ENTITLED
  AN ACT
  relating to prior authorization for prescription drug benefits
  related to the treatment of neurodegenerative diseases.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  The heading to Subchapter N, Chapter 1369,
  Insurance Code, is amended to read as follows:
  SUBCHAPTER N.  COVERAGE OF PRESCRIPTION DRUGS FOR CERTAIN
  [AUTOIMMUNE] DISEASES AND [CERTAIN BLOOD] DISORDERS
         SECTION 2.  Section 1369.654(a), Insurance Code, is amended
  to read as follows:
         (a)  A health benefit plan issuer that provides prescription
  drug benefits may not require an enrollee to receive more than one
  prior authorization annually of the prescription drug benefit for a
  prescription drug prescribed to treat an autoimmune disease,
  hemophilia, a neurodegenerative disease, or Von Willebrand
  disease.
         SECTION 3.  The change in law made by this Act applies only
  to a health benefit plan that is delivered, issued for delivery, or
  renewed on or after January 1, 2026. A health benefit plan
  delivered, issued for delivery, or renewed before January 1, 2026,
  is governed by the law as it existed immediately before the
  effective date of this Act, and that law is continued in effect for
  that purpose.
         SECTION 4.  This Act takes effect September 1, 2025.

Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.